Eric BREUMIER

En résumé

Entreprises

• Ferring - Vice President, European Commercial Operations

  2013 - maintenant En charge des opérations commerciales pour l'Europe.

• Covidien - Vice President Global Marketing, Pipeline Management

  Élancourt 2010 - 2011 In charge of Pipeline Management for Soft Tissue Implants, Biosurgery and Wound Closure at Covidien , based in Trévoux office.

• Galderma - Head of Global Marketing

  Courbevoie 2009 - 2010 Head of Global Marketing for Galderma, based in Paris office. In charge as well for Market Research & Competitive Intelligence, Market Access, Sales Force Effectiveness and Marketing Excellence . Drove organizational change to a more senior structure and making it closer to the markets, the R&D and BD organizations. Strategic change towards Market Access initiatives and Market Insights development . Important impact on Galderma strategic directions, product portfolio value maximization. Successful entry in the corrective and aesthetic dermatology.

• Bristol-Myers Squibb - Global Lead, Metabolic Diseases

  Rueil-Malmaison cedex 2007 - 2009 Global Marketing Director for Dapagliflozin, a novel, selective SGLT2 inhibitor for the treatment of patients with type 2 diabetes. Gained endorsement of key marketing claims and endpoints prioritization for Phase III program . Led the FDC, Phase IIIB and LCM subteams as well as strategic planning and budget. Development of an initial PRO strategy and early payer value story. Member of the Collaborative Full Development Team. Successful experience of effective collaboration with all functions across BMS and Astra Zeneca. Two Spot Awards.

• Bristol-Myers Squibb - Directeur Général

  Rueil-Malmaison cedex 2004 - 2007 Successful launch and development of BMS India operations moving from a start up to a fully fledged BMS operations with 76 employees in December 06. Developed and implemented a new strategy for an accelerated growth. Explored acquisition of an Indian company conducting a due diligence. Pursued licensing opportunities with Global Business Development to add new molecules in our portfolio locally. Worked with TechOps for local manufacturing initiatives. Successfully launched Taxol and Paraplatin. Second country in the world to launch Sprycel working closely with Global and Regional Brand Teams. Successful launch of Baraclude (47 % VMS in 6 months). Launch of a Critical Care franchise reaching a breakeven point in less than six months. Developed and implemented innovative pilots like the Relationship Management Center for services delivery and persistence enhancement or a Patient Partnership Program for broader access to Sprycel. Work with other part of the organization to develop OneBMS in India (GDO hub, GBS, Medical Imaging, Mead Johnson, ..). Worked closely with Patent department to secure first patents in India . Executive member of OPPI (Pharma Industry Association) and Chairman of the Marketing Committee.

Formations

Réseau

• Alexis GAUCHER

• Anne Sophie DEFOUR

• Gonzague DE THÉ

• Jacky CAMBIEN

• Jean Marc BUANNIC

• Olivier LECOMTE